Operational detail for biotech founders raising capital and teams driving BD visibility—audits, evidence rooms, corpus-backed AI, benchmarks, and measurement—without diluting scientific credibility.
A practical map of where your technical evidence lives today and how outsiders are likely to encounter it. Typical deliverables include:
A navigable set of public pages that reduce diligence friction while preserving technical honesty. Outputs often include:
For active raises and BD pushes: combine your public evidence room with a vector-embedded corpus of published science and reputable public-domain sources. Retrieval-augmented generation lets an AI agent brief mechanism, indication, and benchmark context in minutes—anchored in retrieved passages—so founders spend less time repeating the same literature tour for every new firm.
Read the platform overviewContextualize your program against standard of care, relevant comparators, translational benchmarks, and historical category analogs—so non-specialists can orient without misreading novelty.
Reporting can incorporate Google Search Console query and page trends, indexing checks, and analytics engagement indicators. These metrics are interpreted as operational signals, not proof of financing outcomes.
Visibility metrics are directional and operational. They help teams see indexing and query trends; they do not prove fundraising or deal outcomes.
A pragmatic first pass: one audit, one flagship evidence asset, and one reporting setup—scoped so your team can evaluate workflow fit before expanding scope.
Discuss a pilot